ARCHIVES

Tivozanib Trumps Sorafenib In 1st-Line Renal Cancer Study

This article is from The Cancer Letter archive.

Vol. 35 No. 5 | May 25, 2012

Download PDF Visit The Full Archive

Related Articles

Enzastaurin Shows Activity In Recurrent High-Grade Glioma

June 24, 2005

NCI R01 Payline Falls To 12th Percentile In Fifth Year Of No-Growth Budgets.

March 7, 2008

Melanoma Vaccine Near Phase 3, Other Studies Discussed At ACS Seminar

April 13, 1990

Celebrex Studies Show Polyp Reduction, Point To Challenges In Biomarker Validation

April 28, 2006

Former kidney cancer advocate Carl Dixon charged with theft of $335,000 from association.

October 3, 2003

Prime Contract Subcontract Opportunities

January 24, 1975